Lupin launches pregnancy prevention tablets in the US
New Delhi : Pharma major Lupin said it has launched Mibelas 24 Fe, used for pregnancy prevention, in the US market.
"The company today announced the launch of Mibelas 24 Fe (Norethindrone Acetate and Ethinyl Estradiol chewable tablets, 1 mg/0.02 mg and Ferrous Fumarate tablets, 75 mg) having received an approval from the USFDA earlier," Lupin said in a BSE filing.
The tablet is the AB rated generic equivalent of Allergan Pharmaceuticals International Minastrin 24 Fe tablets, it added.
According to IMS MAT December 2016 data, Minastrin 24 Fe chewable tablets had the US sales of USD 360.5 million.
Shares of Lupin closed 0.41 per cent up at Rs 1,456.40 on BSE.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd